Eicosapentaenoic Acid as a Potential Therapeutic Approach to Reduce Cardiovascular Risk in Patients with End-Stage Renal Disease on Hemodialysis: A Review.
| Author | |
|---|---|
| Abstract |
:
Patients with end-stage renal disease on hemodialysis have excess cardiovascular disease (CVD) burden with substantially increased CV event rates compared with the general population. |
| Year of Publication |
:
2017
|
| Journal |
:
Cardiorenal medicine
|
| Volume |
:
8
|
| Issue |
:
1
|
| Number of Pages |
:
18-30
|
| ISSN Number |
:
1664-3828
|
| DOI |
:
10.1159/000479391
|
| Short Title |
:
Cardiorenal Med
|
| Download citation |
